The stock last traded at $373.52 just a bit higher than $351.74, the stock’s 50 day moving average and significantly higher than the 200 day moving average of $315.18. The 50 day moving average went up by +6.19% and the 200 day average went up by +18.51%. Trading volume for Intuitive Surgical, Inc. was 2,021K by the end of trading on Tuesday. Trading volume was up 549.13% over the stocks average daily volume.
Traders are feeling more bullish on Intuitive Surgical, Inc. considering the change in short interest. The firm had a fall in short interest of -8.68% as of the latest report on September 29, 2017. Short interest decreased from 1,820,280 to 1,662,279 over that period. Days to cover increased 1.0 to 8.0 and the short interest percentage is 0.01% as of September 29.
There has been some selling insider activity on Intuitive Surgical, Inc. (NASDAQ:ISRG) recently. EVP – Product Operations Salvatore Brogna let go of 899 shares at an average price of $1,001.90 on September 1st. Brogna now owns $469,891 of stock as recorded in a recent Form 4 SEC filing. Sr VP Mark J. Meltzer disclosed the sale of 500 shares of (ISRG). The shares were purchased at an average price of $982.90. Meltzer now owns $2,256,738 of the stock according to the SEC filing.
These firms have modified their investment in ISRG. State Treasurer State Of Michigan downsized its holdings by selling 800 shares a decrease of 6.6%. State Treasurer State Of Michigan now controls 11,356 shares worth $11,877,000. The total value of its holdings increased 4.5%. Wealthtrust-arizona, LLC bolstered its ownership by buying 4 shares an increase of 80.0% as of 09/30/2017. Wealthtrust-arizona, LLC now holds 9 shares valued at $9,000. The value of the position overall is up by 125.0%.
As of the end of the quarter Alpha Windward LLC had disposed of a total of 12 shares trimming its stake by 4.3%. The value of the investment in (ISRG) increased from $262,000 to $280,000 increasing 6.9% for the reporting period. As of quarter end Robeco Institutional Asset Management B.v. had bought 26,260 shares growing its holdings by 152.4%. The value in dollars went from $16,124,000 to $45,491,000 a change of $29,367,000 quarter to quarter.
October 20 investment analysts at Barclays kept the stock rating at “Overweight” but lowered the price expectation from $750.00 to $370.00. On October 20 Morgan Stanley held the company rating at “Overweight” and raised the price target to $390.00 from $1.00.
October 23 investment analysts at Citigroup left the stock rating at “Buy” and lowered the price expectation to $432.00 from $750.00.
The P/E ratio is 53.67 and market capitalization is 41.63B. As of the last earnings report the EPS was $6.96 and is estimated to be $8.62 for the current year with 111,452,000 shares now outstanding. Analysts expect next quarter’s EPS to be $1.98 and the next full year EPS is projected to be $9.35.
Intuitive Surgical, Inc. (Intuitive), launched on November 9, 1995, designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Business’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery (MIS) procedures. Its da Vinci Surgery utilizes computational, robotic and imaging technologies..